Among various hypotheses, ADAM10 is a promising candidate to bridge the apparent contradiction in risk factors for seizures in AD because of its stage‐dependent involvement in both amyloidogenic processes and cortical dysplasia. The gene discussed is ADAM10; the disease is Alzheimer disease.